Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Techniques in Urology|August 30, 2000
Unilateral nondisseminated actinomycosis of the hydrocele wall: a case report of actinomycosis in the urogenital tractM Remzi, R Buchsteiner, B Djavan, et al.
The Journal of Urology|November 17, 1998
Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./mlA R Zlotta, B Djavan, M Petein, et al.
Urology|July 22, 1999
High-energy transurethral microwave thermotherapy in patients with acute urinary retention due to benign prostatic hyperplasiaB Djavan, C Seitz, K Ghawidel, et al.
Urology|May 1, 1995
Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: changing trends over a 10-year period (1984-1994). Dallas Outcomes Research Group for Urological DisordersS E Litwiller, B Djavan, B V Klopukh, et al.
Neurourology and Urodynamics|March 25, 1999
Interrelationships of bladder compliance with age, detrusor instability, and obstruction in elderly men with lower urinary tract symptomsS Madersbacher, A Pycha, C H Klingler, et al.
European Urology|November 20, 2001
Human accessory cells activate fresh, normal, tumor-distant T lymphocytes but not tumor-infiltrating T lymphocytes to lyse autologous tumor cells in a primary cytotoxic T lymphocyte assay in renal cell carcinomaG Kramer, G E Steiner, S Paiha, et al.
European Urology|July 21, 2001
Spatial distribution of prostate cancers undetected on initial needle biopsiesP R Mazal, A Haitel, C Windischberger, et al.
Urology|September 4, 1999
PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mLB Djavan, A Zlotta, C Kratzik, et al.
The Journal of Urology|March 29, 2000
Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 menB Djavan, A Zlotta, M Remzi, et al.
Urology|February 2, 2000
Pretreatment prostate-specific antigen as an outcome predictor of targeted transurethral microwave thermotherapyB Djavan, B Bursa, A Basharkhah, et al.
Pageof 8